Found: 7
Select item for more details and to access through your institution.
Total and H‐specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3147, doi. 10.1111/dom.15642
- By:
- Publication type:
- Article
Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6‐month long interventional study
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2561, doi. 10.1111/dom.15141
- By:
- Publication type:
- Article
Effect of the glucagon‐like peptide‐1 analogue liraglutide versus placebo treatment on circulating proglucagon‐derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 489, doi. 10.1111/dom.14242
- By:
- Publication type:
- Article
Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02264-5
- By:
- Publication type:
- Article
Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non‐alcoholic steatohepatitis.
- Published in:
- Liver International, 2021, v. 41, n. 8, p. 1853, doi. 10.1111/liv.14888
- By:
- Publication type:
- Article
Leptin alters energy intake and fat mass but not energy expenditure in lean subjects.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-18885-9
- By:
- Publication type:
- Article
A multicriteria approach for rating investments in commercial real estate.
- Published in:
- International Transactions in Operational Research, 2023, v. 30, n. 5, p. 2189, doi. 10.1111/itor.12914
- By:
- Publication type:
- Article